Congratulations to Valerie Andrees (on the right) for winning the "Young Investigator Award - Health Care Research 2023" presented by CHCR&PH! 🎉👏 She found that #psoriasis and its #comorbidities occur with strong regional #prevalence differences. 🗺️ 👉 pubmed.ncbi.nlm.nih.gov/35316303/

Welche #Nahrungsergänzungsmittel🌱sind für Frauen👩‍🦱in der Lebensmitte sinnvoll? Und welche sind bloß Geldmacherei? Das erklärt Frau Prof. Dr. Zyriax in der neuen Folge des BRIGITTE WOMAN Podcasts "MENO AN MICH. Frauen mitten im Leben." 👉Hören Sie rein: podcastbrigitte.spread.link/meno-an-mich-f…

Die Qualität der #Gesundheitsversorgung bei #Psoriasis 🖐️ ist in Dänemark, Deutschland, Polen & Spanien auch aus Sicht der Patient*innen unterschiedlich. Eine Ursache könnte im ungleichen Zugang zu innovativen #Arzneimitteln 💊 liegen. Zum Artikel 👉 medicaljournalssweden.se/actadv/article…

Congratulations to Merle Juschka & Caroline Johanna Agricola for winning the first prize 🏆 with their poster on "Interprofessional Education of Midwifery and Medical Students (IPE MidMed)" at the Lübeck Interprofessional Perinatal Congress. #midwives #midwiferycare #education

Jedes Jahr werden im Rahmen der The Women's Image Awards die "IT-Women of the Year" gekürt! 👩‍💻🏆 Diesmal ist Marina Otten für ihre Forschung auf dem Gebiet eHealth nominiert. #WINAwards #FITKongress 🥁 Stimmt jetzt für sie ab! umfragen.vogel-it.de/WIN-Umfrage/16… ➡️Women in eHealth ➡️Leadership

New insights into #skincancer #screening 🔎 in Germany: Among 8.2 Mio. participants per year (32% participation rate), 4.2% had a skin cancer finding; compared to non-participants, 15% less interval tumours were observed. #dermatology #preventivehealth 👉 pubmed.ncbi.nlm.nih.gov/38063281/

1.5 or 2.0 million? How do we get valid information on #psoriasis #epidemiology from German claims data? 🤔 New method study reveals pitfalls and solutions. #PsoriasisResearch #StatutoryHealthInsuranceData Find out more: pubmed.ncbi.nlm.nih.gov/38063281/

New development in #PsoriasisResearch! Introducing Patient Benefit Index for Topical Psoriasis Therapy (PBI-TOP). Assessing treatment goals' importance and achievement, it contributes to the understanding of patients’ experiences with topical therapy.👏 👉pubmed.ncbi.nlm.nih.gov/38213122/

🌊🏞️ Neue Studie zu den #Hochwasserfolgen im #Ahrtal 2021: Markanter Anstieg bei hochwasserbedingten Verletzungen und psychischen Erkrankungen. Auswirkungen auf die #Gesundheit der lokalen Bevölkerung zeigen die Notwendigkeit angepasster Schutzmaßnahmen. pubmed.ncbi.nlm.nih.gov/38193912/

Vielen Dank für die spannenden Vorträge und inspirierenden Gespräche vorletzte Woche auf der HEBA-PÄD und der Konferenz der #DGHWi! 🩺 Außerdem nochmals herzlichen Glückwunsch an Valeen Kölling, deren Bachelorarbeit von der #DGHWi mit dem 2. Posterpreis ausgezeichnet wurde. 🥳

🙋‍♀️ Heute ist Tag der Seltenen Erkrankungen! #RareDiseaseDay Der 29. Februar ist der seltenste aller Tage – das passende Datum, um auf die Belange von Betroffenen mit Seltenen Erkrankungen aufmerksam zu machen. 🔬💊 #MySkinIsRare Mehr Infos gibt es hier: rarediseasesinternational.org/living-with-a-…

Women feel that guidance on #nutrition during #pregnancy is inadequate.🤰🍏 Our findings suggest: ➡️ consistent information from #healthcare professionals to tackle internet confusion ➡️ free personalized nutrition counseling in #prenatal care #midwifery pubmed.ncbi.nlm.nih.gov/38383376/

📊🌐 German pre-post-pandemic study reveals: Persisting concerns on #eHealth, moderate interest and only minor increase in #teledermatology. Rural areas particularly affected. #dermatology pubmed.ncbi.nlm.nih.gov/38345855/

Alopecia areata (AA), a chronic immune-mediated #disease causing hair loss, affects 210 per 100,000 in Germany. Persons with AA often have conditions like atopic #dermatitis and #psoriasis, highlighting the need for comprehensive care. #PublicHealth pubmed.ncbi.nlm.nih.gov/37852247/

📊📄Many with atopic #dermatitis in Germany are prescribed systemic glucocorticosteroids (SGCs) for longer than recommended, raising risks like #osteoporosis and #diabetes. We urge limiting SGC use and supporting safer long-term treatments. #Health 📝👇🏻 pubmed.ncbi.nlm.nih.gov/38924726/

📊📄500,000 adults in Germany have #hyperhidrosis (HH). Localized HH is more common in younger people, generalized HH in older adults. The findings stress the need for better #data to improve HH #care. #Epidemiology #HealthcareResearch 👇🏻📝👇🏻 pubmed.ncbi.nlm.nih.gov/39134433/#:~:t….

📄Self-stigma in chronic #skin diseases is common and affects quality of life. A systematic #review evaluated interventions to reduce self-stigma, with positive effects. However, the #quality of studies varied, emphasizing the need for more improvement. 👇🏻pubmed.ncbi.nlm.nih.gov/39254291/

📊📄A study from the German #PsoBest registry highlights the challenges faced by #women of childbearing age (18–45) with #psoriasis compared to men and older women. These insights emphasize the need for #gender- and age-tailored psoriasis #care. 📝👇🏻👇🏻👇🏻 pubmed.ncbi.nlm.nih.gov/39263467/

📝People with visible skin conditions like #dermatitis, #psoriasis, #vitiligo, and #alopecia often face social and self-stigma. A new review explores factors behind this burden and highlights targets for psychosocial interventions. #HealthAwareness 📄👇🏻 pubmed.ncbi.nlm.nih.gov/39247975/